{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:07:45Z","timestamp":1774933665174,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.nbd.2018.05.020","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:03:01Z","timestamp":1527811381000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Neuronal levels and sequence of tau modulate the power of brain rhythms"],"prefix":"10.1016","volume":"117","author":[{"given":"Melanie","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumihiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bozhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Qiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Mucke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.05.020_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2017.03.030","article-title":"Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: An EEG study","volume":"55","author":"Babiloni","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.05.020_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.05.020_bb0015","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","article-title":"Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention asessed by fMRI and memory task performance","volume":"7","author":"Bakker","year":"2015","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nbd.2018.05.020_bb0020","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-017-00618-0","article-title":"Tau exacerbates excitotoxic brain damage in an animal model of stroke","volume":"8","author":"Bi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.05.020_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.nbd.2018.05.020_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12692","article-title":"Interplay of pathogenic forms of human tau with different autophagic pathways","volume":"17","author":"Caballero","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2018.05.020_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-2010-100285","article-title":"Tau protein role in sleep-wake cycle","volume":"21","author":"Cantero","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2018.05.020_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-130098","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808","volume":"38","author":"Chien","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2018.05.020_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.clinph.2011.09.012","article-title":"Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-na\u00efve epilepsy patients","volume":"123","author":"Cho","year":"2012","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0920-1211(00)00167-4","article-title":"EEG frequency profiles of idiopathic generalised epilepsy syndromes","volume":"42","author":"Clemens","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2018.05.020_bb0060","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1093\/hmg\/dds161","article-title":"Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer\u2019s diseases","volume":"21","author":"Coppola","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.05.020_bb0065","first-page":"367","article-title":"Alzheimer\u2019s disease drug development pipeline: 2017","volume":"3","author":"Cummings","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2018.05.020_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpsycho.2007.11.002","article-title":"Quantitative EEG in early Alzheimer\u2019s disease patients \u2013 power spectrum and complexity features","volume":"68","author":"Czigler","year":"2008","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.15252\/embr.201541439","article-title":"The Tau\/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity","volume":"17","author":"Decker","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2018.05.020_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2014.00011","article-title":"Mechanisms of levetiracetam in the control of status epilepticus and epilepsy","volume":"5","author":"Deshpande","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0085","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","article-title":"Antisense reduction of tau in adult mice protects against seizures","volume":"33","author":"Devos","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.05.020_bb0095","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neuron.2016.12.023","article-title":"Tau pathology induces excitatory neuron loss, grid cell dysfunction, and spatial memory deficits reminiscent of early Alzheimer's disease","volume":"93","author":"Fu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.05.020_bb0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2013.06.005","article-title":"Hyperexcitability and epileptic seizures in a model of frontotemporal dementia","volume":"58","author":"Garcia-Cabrero","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.05.020_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.24230","article-title":"Tau reduction prevents disease in a mouse model of Dravet syndrome","volume":"76","author":"Gheyara","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0120","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-160994","article-title":"Sleep EEG detects epileptiform activity in Alzheimer\u2019s disease with high sensitivity","volume":"56","author":"Horv\u00e1th","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2018.05.020_bb0125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.05.020_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jnc.12967","article-title":"P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway","volume":"132","author":"Hunsberger","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.05.020_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.05.020_bb0140","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinph.2004.01.001","article-title":"EEG dynamics in patients with Alzheimer\u2019s disease","volume":"115","author":"Jeong","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/srep20119","article-title":"Interictal spikes during sleep are an early defect in the Tg2576 mouse model of \u03b2-amyloid neuropathology","volume":"6","author":"Kam","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2018.05.020_bb0150","doi-asserted-by":"crossref","first-page":"223.E7","DOI":"10.1016\/j.neurobiolaging.2012.04.006","article-title":"The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features","volume":"33","author":"Kara","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.05.020_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138866","article-title":"Predicting progression from mild cognitive impairment to Alzheimer's Dementia using clinical, MRI, and plasma biomarkers via probabilistic pattern classification","volume":"11","author":"Korolev","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.05.020_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5414\/NPP30003","article-title":"Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7","volume":"30","author":"Kovacs","year":"2011","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm.4330","article-title":"Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease","volume":"23","author":"Lam","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.05.020_bb0170","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WAD.0b013e31828cc357","article-title":"Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease","volume":"27","author":"Lee","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.nbd.2018.05.020_bb0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","article-title":"Tau-based therapies in neurodegeneration: Opportunities and challenges","volume":"16","author":"Li","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2018.05.020_bb0180","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.neurobiolaging.2014.05.001","article-title":"Seizure resistance without parkinsonism in aged mice after tau reduction","volume":"35","author":"Li","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.05.020_bb0185","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awx005","article-title":"A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction","volume":"140","author":"Lopez","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.05.020_bb0190","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond","volume":"30","author":"L\u00f6scher","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2018.05.020_bb0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.15252\/embr.201541438","article-title":"Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice","volume":"17","author":"Maeda","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2018.05.020_bb0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ana.21326","article-title":"Frequency and course of mild cognitive impairment in a multiethnic community","volume":"63","author":"Manly","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnins.2015.00196","article-title":"Loss of tau rescues inflammation-mediated neurodegeneration","volume":"9","author":"Maphis","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0210","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.05.020_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","article-title":"Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture","volume":"12","author":"Miyamoto","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.05.020_bb0220","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0811699106","article-title":"Altered temporal correlations in parietal alpha and prefrontal theta oscillations in early-stage Alzheimer disease","volume":"106","author":"Montez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.05.020_bb0225","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.05.020_bb0230","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2012.12.003","article-title":"Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice","volume":"34","author":"Morris","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.05.020_bb0235","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/acn3.257","article-title":"Network dysfunction in \u03b1-synuclein transgenic mice and human Lewy body dementia","volume":"2","author":"Morris","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.05.020_bb0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer\u2019s disease mouse model","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2018.05.020_bb0250","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","article-title":"Reduction of soluble A\u03b2 and tau, but not soluble A\u03b2 alone, ameliorates cognitive decline in transgenic mice with plaques and tangles","volume":"281","author":"Oddo","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.05.020_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-016-0096-1","article-title":"Tau mutant A152T, a risk factor for FTD\/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model","volume":"11","author":"Pir","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2018.05.020_bb0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jnc.13622","article-title":"Genetics of FTLD: Overview and what else we can expect from genetic studies","volume":"138","author":"Pottier","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.05.020_bb0265","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","article-title":"Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease","volume":"75","author":"Quiroz","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0270","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.05.020_bb0275","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0280","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.05.020_bb0285","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"SantaCruz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.05.020_bb0290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.seizure.2007.12.009","article-title":"Analysis of background EEG activity in patients with juvenile myoclonic epilepsy","volume":"17","author":"Santiago-Rodr\u00edguez","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.nbd.2018.05.020_bb0295","doi-asserted-by":"crossref","first-page":"781731","DOI":"10.1155\/2015\/781731","article-title":"Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer\u2019s disease","volume":"2015","author":"Siwek","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2018.05.020_bb0300","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40478-017-0489-6","article-title":"Atypical, non-standard functions of the microtubule associated Tau protein","volume":"5","author":"Sotiropoulos","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2018.05.020_bb0305","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1523\/JNEUROSCI.5245-10.2011","article-title":"Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant","volume":"31","author":"Sydow","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0310","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2016.03.005","article-title":"Acetylated tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes tauopathy-related memory loss","volume":"90","author":"Tracy","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.05.020_bb0315","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0320","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.05.020_bb0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.05.020_bb0330","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.stemcr.2017.08.019","article-title":"Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening","author":"Wang","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2018.05.020_bb0335","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2018.05.020_bb0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-2012-120712","article-title":"A highly selective and specific PET tracer for imaging of tau pathologies","volume":"31","author":"Zhang","year":"2012","journal-title":"J. Alzheimers Dis."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611830158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611830158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:13:32Z","timestamp":1760850812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611830158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":68,"alternative-id":["S096999611830158X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.05.020","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal levels and sequence of tau modulate the power of brain rhythms","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}